İHALE DÜNYASI
İHALE DÜNYASI
Levomefolate Calcium/Acetylcysteine/Mecobalamin/Algal Powder (6 mg-600 mg-2 mg-90.314 mg) is an orally administered prescription dietary supplement, and should be administered under the supervision of a licensed medical practitioner. INGREDIENTS: This product contains the following dietary ingredients: L-Methylfolate Calcium CAS #151533-22-1 6 mg Methylcobalamin 2 mg N-Acetyl-L-Cysteine 600 mg Algae Powder (schizochytrium) 90.314 mg Other Ingredients: Silicified Microcrystalline Cellulose NF, Polyvinyl Alcohol, Croscarmellose Sodium NF, Titanium Dioxide, Polyethylene Glycol 3350, Magnesium Stearate (NF, Vegetable Source), Talc, Beet Powder Red (color), Caramel FCC (color), Carnauba Wax.
Levomefolate Calcium/Acetylcysteine/Mecobalamin/Algal Powder (6 mg-600 mg-2 mg-90.314 mg) is indicated for the distinct nutritional requirements of patients in need of advanced vitamin B 9 supplementation-specifically suboptimal vitamin B 9 or maintenance-level needs, as determined by a licensed medical practitioner.
Usual adult dose is one caplet daily or as prescribed by a licensed medical practitioner. Store at controlled room temperature 15°-30°C (59°-86°F). [See USP]. Protect from light and moisture. Dispense in a tight, light-resistant container. Notice: Contact with moisture may produce surface discoloration or erosion. Call your medical practitioner about side effects. You may report side effects by calling 813-283-1344.
This product is contraindicated in patients with a known hypersensitivity to any of the components contained in this product.
Allergic reactions have been reported following the use of oral and parenteral vitamin B 9 . Mild transient diarrhea, polycythemia vera, itching, transitory exanthema and the feeling of swelling of the entire body has been associated with cobalamin. Nausea, vomiting, diarrhea, transient skin rash, flushing, epigastric pain, and constipation have been associated with acetylcysteine. Call your medical practitioner about side effects.
Caution is recommended in patients with a history of bipolar illness. Mood elevation is possible in this population. Caution is also recommended in patients taking anticonvulsant medications as vitamin B 9 may interfere with anticonvulsant medication, and may lower seizure threshold. Patients undergoing cancer treatment should consult their licensed medical practitioner for advice.
